Nexalin Technology Inc (NXL)

Currency in USD
4.9500
-0.1600(-3.13%)
Real-time Data·
NXL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.95005.3599
52 wk Range
4.510160.0000
Key Statistics
Prev. Close
5.0992
Open
5.0613
Day's Range
4.95-5.3599
52 wk Range
4.5101-60
Volume
10.24K
Average Volume (3m)
9.82K
1-Year Change
-79.1007%
Book Value / Share
2.12
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NXL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
60.0001
Upside
+1,112.12%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Nexalin Technology Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 60.0001
(+1,112.12% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy2.00-59.60%4.00MaintainApr 07, 2026

Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
-0.11 / -0.10
Revenue / Forecast
12.16K / 90K
EPS Revisions
Last 90 days

NXL Income Statement

Compare NXL to Peers and Sector

Metrics to compare
NXL
Peers
Sector
Relationship
P/E Ratio
−0.4x−2.3x−0.4x
PEG Ratio
−0.01−0.130.00
Price/Book
2.4x5.8x2.6x
Price / LTM Sales
16.9x2.2x3.0x
Upside (Analyst Target)
-77.4%55.0%
Fair Value Upside
Unlock−5.0%7.6%Unlock

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer’s disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.24K1.39%50.37K
Other Institutional Investors
225.50K30.70%1.11M
Public Companies & Retail Investors
498.81K67.91%2.45M
Total
734.55K100.00%3.61M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Alumni Capital LP10.98%80,645397
Alumni Capital Management10.98%80,645397

People Also Watch

3.37
CYCU
-1.46%
7.7500
DFNS
-1.65%
4.0601
TNON
-3.33%
5.1950
FCUV
-1.52%
0.843
PDSB
+0.11%

FAQ

What Is the Nexalin Technology (NXL) Stock Price Today?

The Nexalin Technology stock price today is 4.9500 USD.

What Stock Exchange Does Nexalin Technology Trade On?

Nexalin Technology is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Nexalin Technology?

The stock symbol for Nexalin Technology is "NXL."

What Is the Nexalin Technology (NXL) Afterhours Price Today? (Afterhours variable test: 5.1100) Current Date: Sep 18, 2026

After hours price: 5.1100. After hours price change (units): 0.0108. Price change percentage: 0.2100%

What Is the Nexalin Technology Market Cap?

As of today, Nexalin Technology market cap is 3.7500M USD.

What Is Nexalin Technology's Earnings Per Share (TTM)?

The Nexalin Technology EPS (TTM) is -13.9203.

When Is the Next Nexalin Technology Earnings Date?

Nexalin Technology will release its next earnings report on Dec 02, 2026.

From a Technical Analysis Perspective, Is NXL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nexalin Technology Stock Split?

Nexalin Technology has split 1 times.

What is the current trading status of Nexalin Technology (NXL)?

As of Sep 18, 2026, Nexalin Technology (NXL) is trading at a price of 4.9500 USD, with a previous close of 5.0992 USD. The stock has fluctuated within a day range of 4.9500 USD to 5.3599 USD, while its 52-week range spans from 4.5101 USD to 60.0000 USD.

What Is Nexalin Technology (NXL) Price Target According to Analysts?

The average 12-month price target for Nexalin Technology is 60.0001 USD, with a high estimate of 60.00006 USD and a low estimate of 60.00006 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +1,112.12% Upside potential.

What Is the NXL After Hours Price?

NXL's last after hours stock price is 5.1100 USD, the stock has decreased by 0.0108, or 0.2100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.